MEDIA CENTER2018-11-19T17:53:23-06:00

Latest news from Rapha Capital Management & our portfolio companies

Bellicum Pharmaceuticals, Inc.
Bellicum Reports Safety Results and Promising Activity of Its Controlled CAR-T Candidate BPX-601 in Patients with Advanced Pancreatic Cancer at ESMO-IO
Rimiducid-activated GoCAR-T® resulted in significant expansion and persistence of T cells
Initial evidence of biologic activity and stable disease observed in some patients with single rimiducid dose
BPX-601 was well-tolerated with no CRS or neurotoxicity reported in initial cell-dose escalation
Company to add additional tumor types in Part 2 of study, incorporating standard lymphodepletion and repeat rimiducid dosing
December 14, 2018

Numat Technologies
A Material to Save the World?
Metal-organic frameworks are compounds that are set to solve some tough challenges: producing water in the desert, removing greenhouse gases from the air and storing dangerous gases more safely.
November 5, 2018

Go to Top